This issue of EuroIntervention has two State-of-the-Art reviews: the first, on the management of NSTE-ACS, and the second, on calcified nodules and PCI; our Original Research articles examine beta blockers after MI; abbreviated versus standard antiplatelet therapy in high bleeding risk patients with chronic kidney disease; we finish with a Flashlight on thrombosis after coronary sinus Reducer migration; and more...
Original Research
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trial
Rossello X, Sánchez P, Owen R, Raposeiras-Roubin S, Poletti F, Barrabés J, Anguita M, Dominguez-Rodriguez A, Lombardi M, Pocock S, Díez-Villanueva P, Vives-Borras M, Rollán M, D’Orazio S, Escalera N, Isabel-Santos A, Chiampan A, de Diego O, López-Benito M, Moreno E, Rincón-Díaz L, París H, Latini R, Fuster V, Ibáñez B
10.4244/EIJ-D-25-00826
open access
Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: prespecified analysis from the MASTER DAPT trial
Landi A, Mahfoud F, Frigoli E, Chalkou K, Heg D, Abhaichand R, Abhyankar A, Barbato E, Beygui F, Danse P, Garachemani A, del Blanco B, Huber K, Koning R, Kukreja N, Piot C, Quang N, Tirouvanziam A, Valla M, Smits P, Valgimigli M, obotMDi
10.4244/EIJ-D-25-00566
